PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland

Gdańsk, Poland – 11 March 2024 – PolTREG S.A. , a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases, today announces it has received CGMP...

Related Keywords

Poland ,Douwe Miedema ,Piotr Trzonkowski ,Chris Maggos ,Globenewswire Inc ,Poltreg Sa Warsaw Stock Exchange ,Office For Registration Of Medicinal Products ,Cohesion Bureau ,Warsaw Stock Exchange ,Chief Pharmaceutical Inspectorate ,Advanced Therapy Medicinal Products ,Medicinal Products ,Medical Devices ,Biocidal Products ,Multiple Sclerosis ,Chief Executive Officer ,Amyotrophic Lateral Sclerosis ,Markets ,